|
|
Mark Baum to Speak at LSTCON
Mark Baum, founder and CEO of Harrow Health, Inc., a new, exciting entry to Tennessee’s biotech industry, will be a keynote speaker at LSTCON on Nov. 14. He will discuss biopharma industry opportunities for our region and the mission of Harrow Health. In June, Gov. Bill Lee announced Harrow Health would relocate its headquarters to Nashville.
Harrow Health owns a portfolio of health care businesses, including ImprimisRx, the nation’s leading ophthalmology pharmaceutical compounding business. Baum is also a founder and board member of Eton Pharmaceuticals, Surface Pharmaceuticals, Melt Pharmaceuticals, Mayfield Pharmaceuticals, Radley Pharmaceuticals and Stowe Pharmaceuticals.
Prior to Harrow Health, Baum was a senior advisor to VC-backed Curology.com; the founder of TBLF, LLC, a private investment fund manager; and the founder of YesRx, an HIV-focused pharmacy business. Advocating for access and affordability has been central to Baum's two decades in the pharmaceutical sector.
Can't wait to hear what he has to say?
| |
Applications Open for the 2019 Venture Forum
We are currently accepting applications for this year’s Venture Forum during LSTCON. The Venture Forum, sponsored by Waller Lansden Dortch & Davis and Launch Tennessee, is a unique pitch competition for Tennessee's emerging life science startups.
Qualified companies can apply here. Please note that in addition to completing this application, applicants must also send an executive summary to Danielle Pyle at dpyle@lifesciencetn.org. Companies may submit applications until Sept. 20.
| |
|
Thank you to our LSTCON sponsors
| |
|
36|86 This Month
36|86 Entrepreneurship Festival will take over downtown Nashville at the end of this month. Powered by LaunchTN, the two-day festival brings together entrepreneurs, VCs, executives, students and ecosystem builders to downtown Nashville for practical advice, dynamic programming, networking opportunities and entertainment—all designed to give you the knowledge and connections you need to grow your business.
Looking to Hire?
Friday and Saturday, the 36|86 Pavilion at Live On The Green music festival will feature a Startup Job Fair. This casual networking opportunity is open to job-seekers looking to join a fast-growing startup, as well as young startups scouting for talent to scale their businesses. Click here to apply for a spot to recruit talent for your company!
Vote for Healing InnovationsVoting for the Crowd Favorite contest as part of the LaunchTN Pitch Competition is underway. Vote for Life Science Network graduate Healing Innovations who developed a revolutionary neurorehabilitation device called the Rise&Walk.
| |
Save with Scientist.com
Click here for exciting new offerings for LST members. Scientist.com’s Trial Insights is the industry’s first digital reporting system made specifically to provide on-demand insight into ongoing clinical trial, observational, diagnostic and medical device studies. The solution aggregates content from multiple public data sources, including ClinicalTrials.gov, to provide users with comprehensive, customizable dashboard-based reports. Access to the dashboard has been discounted for members. In addition, keep an eye out for information on a webinar later this month.
| |
LST Member Opportunities
Apply
- *NEW* SEBIO Investor & Partnering Forum: Introduce your company to targeted investors, VCs and potential partners at the 2019 Southeast BIO Investor & Partnering Forum by presenting. The Forum provides opportunities for early stage companies that are looking for investment and business partners. The deadline to apply is Aug. 15. Click here to apply.
- *NEW* ISCTM New Investigator Award: The International Society for CNS Clinical Trials and Methodology has created a program to recognize promising new investigators across the broad range of methodological, regulatory and substantive programmatic interests of the society. Applicants can submit a poster abstract based on original research in the field of CNS Trial Methodology for which the applicant will serve as presenting author; a one page statement of research and career interests; a complete CV; and one letter of reference. Applications are due on or before Nov 1. Learn more and apply here.
- Patents2Products Fellowship Program: The University of Memphis and Epicenter have partnered to create a new program designed to hire post-doc fellows to start businesses, using patented intellectual property developed both in Memphis and across the United States. Starting this fall, Patents2Products Post-Doc program creates a two-year funded position for research entrepreneurs and provides them with the necessary tools for a launching a successful startup. For more information or to apply, click here.
Attend
- *NEW* Developing Health Care Ventures: Join Nashville Health Care Council and Nashville Capital Network for an in-depth discussion on Aug. 27 with some of health care's brightest entrepreneur investors. Panelists will reveal insights into their own journeys and how they use their unique experiences to advise new companies. Learn more and register here.
- The MedTech Conference: From Sept. 23-25, more than 3,000 of the world’s top medtech executives will gather in Boston, MA, for the leading event in our industry—the MedTech Conference. Featuring world‑class plenary speakers, cross‑cutting educational programming, valuable networking and business development opportunities, The MedTech Conference is a must‑attend event for the industry’s prominent and most promising companies. Register now.
- SEBIO Forum: The Southeast BIO (SEBIO) Investor & Partnering Forum will be held Nov. 6-7 at The Biltmore in Miami-Coral Gables, FL. The conference provides an unparalleled opportunity to meet key decisionmakers in the regional and national life science and medical technology communities. Register today.
| |
|
LST News Integra LifeSciences Holdings Corporation, a leading global medical technology company based in New Jersey, announced yesterday that it has acquired Arkis Biosciences Inc., a privately-held company that offers a portfolio of neurosurgical devices. Among them is the CerebroFlo® external ventricular drainage (EVD) catheter with Endexo®technology, a permanent additive designed to reduce the potential for catheter obstruction due to thrombus formation.
The company is Hera Health Solutions, appropriately from Memphis. It is a pharmaceutical device company specializing in the development and commercialization of long-acting treatments through proprietary bioerodible implants. Between now and the event, 70 more participants will be announced. Memphis-based Start Co. is co-producing the three-day event along with the Established Team.
In addition to the 18 startups recently inducted into the Nashville Entrepreneur Center's Project Healthcare Portfolio, eight others have been invited to participate in a modified curriculum, now being tailored for piloting. According to EC Product Experience and Marketing Lead Jon Martz, the pilot's curriculum will be very similar to the Portfolio template, with some adjustments to optimize the program for this set of companies.
The strategy includes the newly finalized Inpatient Prospective Payment System rule for fiscal year 2020. The final rule will allow drugmakers to receive add-on payments for some new antibiotics even if they don't meet some U.S. Food and Drug Administration clinical improvement criteria. That add-on payment will also be increased from 50% to 75%, Verma said.
The plan has two parts, the first being a notice of proposed rulemaking that creates a pilot project for states, wholesalers and pharmacists on how they would import drugs from Canada at a cheaper price than in the U.S. The second part is a guidance from the FDA to manufacturers of FDA-approved drugs that would be imported from Canada into the U.S. The guidance would allow the manufacturer to offer a lower price than what their current distribution contracts require in order to compete with the imported drug price.
| |
If you have company news or events to share with us, please send to:
| |
|
|
|
|
